年別の研究成果
年別の研究成果
検索結果
-
2023
Correction: Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCREST-CD) (Journal of Gastroenterology, (2022), 57, 11, (867-878), 10.1007/s00535-022-01907-2)
iCREST-CD Study Group, 2023/06, In: Journal of Gastroenterology. 58, 6, p. 602-603 2 p.研究成果: ジャーナルへの寄稿 › コメント/討論
2 被引用数 (Scopus) -
2019
Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study (PLoS ONE (2019) 14:2 (e0212989) DOI: 10.1371/journal.pone.0212989)
Motoya, S., Watanabe, K., Ogata, H., Kanai, T., Matsui, T., Suzuki, Y., Shikamura, M., Sugiura, K., Oda, K., Hori, T., Araki, T., Watanabe, M. & Hibi, T., 2019/04, In: PLoS ONE. 14, 4, e0215491.研究成果: ジャーナルへの寄稿 › コメント/討論
Open Access2 被引用数 (Scopus) -
2018
Correction to: Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study (Journal of Gastroenterology, (2018), 53, 4, (494-506), 10.1007/s00535-017-1376-4)
Naganuma, M., Aoyama, N., Tada, T., Kobayashi, K., Hirai, F., Watanabe, K., Watanabe, M. & Hibi, T., 2018/04/01, In: Journal of Gastroenterology. 53, 4, p. 579-581 3 p.研究成果: ジャーナルへの寄稿 › コメント/討論
Open Access1 被引用数 (Scopus)